Filter by: patients
What is Penicillin VK?

Penicillin V potassium (K) is an antibiotic used in the treatment of infections caused by susceptible organisms involving the respiratory tract, otitis media, sinusitis, skin, and urinary tract; It is also used as prophylaxis in rheumatic fever.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 4 0
refractory cellulitis of the lower left leg 1 1 Efficacy_slight
General health 1 0
exacerbation of cellulitis infection 1 0
tooth abcess 1 1 Efficacy_major
abcessed molar 1 1 Efficacy_major

See all 4 patients currently taking Penicillin VK

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
4

Reported Dosages

  250 mg daily 2,000 mg daily
  2 Number of Patients: 2 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Penicillin VK (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 7   Course of treatment ended: 88%
Personal research 1   Personal research: 13%
Doctor's advice 1   Doctor's advice: 13%
Other 1   Other: 13%

See all 8 patients who’ve stopped taking Penicillin VK

Currently Taking Penicillin VK

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Penicillin VK

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Penicillin VK

Always
5 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Penicillin VK

Very
0 0%
Somewhat
1 20%
A little
1 20%
Not at all
3 60%

Cost

Paid out of pocket

Cost of Penicillin VK

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 20%
< $25
4 80%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.